Adyen nominates Herna Verhagen as Supervisory Board member and Chair

January 20, Amsterdam - Adyen N.V. announces that the Supervisory Board has nominated Herna Verhagen for appointment as a member of the Supervisory Board, with effect from the Annual General Meeting of Shareholders to be held on May 28, 2026 (Adyen’s Annual General Meeting).

Piero Overmars, who has served multiple terms on the Supervisory Board since January 2017, will not stand for re-election as Chair of the Supervisory Board upon the expiry of his current term. Subject to her appointment, the Supervisory Board intends to elect Herna Verhagen as Chair following the retirement of Piero Overmars.

Herna Verhagen brings more than 20 years of experience in executive and non-executive leadership roles. She previously served as Chief Executive Officer of PostNL N.V. and has been a member of the Supervisory Board of ING Groep N.V. since 2019 and of Royal Philips N.V. since 2022.

“We are very pleased to nominate Herna Verhagen for appointment to our Supervisory Board,” said Caoimhe Keogan, Vice Chair of the Supervisory Board and Chair of the Nomination and Remuneration Committee. “Herna brings extensive experience from both executive and non-executive roles. We are confident that the Supervisory Board will benefit from her broad knowledge and judgment as Adyen continues to scale its platform.” Keogan continues: “We thank Piero Overmars for his commitment and his role as an outstanding Chair, and express our deep appreciation for his significant contributions during his tenure.”

Herna Verhagen: “Adyen is a company that has grown rapidly by building technology at the core of everything it does. I am impressed by the company’s entrepreneurial energy, technological depth, and the enthusiasm with which its teams continue to scale a truly global platform. I look forward to contributing to Adyen’s long-term growth.”

The proposed appointment has been approved by the Dutch Central Bank ( De Nederlandsche Bank ) and will be submitted for approval to shareholders at Adyen’s Annual General Meeting. Piero Overmars will step down from the Supervisory Board toward the end of 2026.

About Adyen

Adyen (ADYEN:AMS) is the financial technology platform of choice for leading companies. By providing end-to-end payments capabilities, data-driven insights, and financial products in a single global solution, Adyen helps businesses achieve their ambitions faster. With offices around the world, Adyen works with the likes of Meta, Uber, H&M, eBay, and Microsoft.

Important Legal Information

This press release contains information that qualifies, or may qualify, as inside information within the meaning of Article 7(1) to (4) of Regulation (EU) No 596/2014 (Market Abuse Regulation).

Any person who comes into possession of this document must inform themselves about and comply with any legal restrictions governing possession, distribution, or use of the document.

Forward-looking statements are not facts and only represent the current views and assumptions of Adyen N.V. (“Adyen”) regarding future events, many of which are by nature inherently uncertain and beyond Adyen’s control. Factors that could cause actual results to deviate materially from those anticipated by forward-looking statements include, but are not limited to, macroeconomic, demographic and political conditions and risks, actions taken and policies applied by governments, financial regulators and private organizations (including payment schemes and credit rating agencies), market conditions and turbulence in financial and other markets, and the success of Adyen in managing the related risks. Subject to statutory obligations, Adyen does not intend to publicly update or revise forward-looking statements to reflect events or circumstances after the date the statements were made, and assumes no obligation to do so.

Adyen does not consent to, authorize, endorse, support, encourage, or participate in, directly or indirectly, unsponsored depository receipt (“DR”) programs regarding Adyen securities. Adyen specifically disclaims any liability whatsoever arising out of or in connection with any unsponsored DR program.